Physician profile
Robert K Altman
NPI 1588788814
$3,807.20
in general payments reported to CMS, 2019-2025
9 companies · $569 in 2025
The $569 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $788 · 2021: $1,665 · 2022: $488 · 2023: $96.63 · 2024: $201 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $1,342.13 | 2019-2024 | Carto 3 |
| Boston Scientific Corporation | $1,080.00 | 2019-2025 | General - Therapies, Watchman Flx, Accolade Sr |
| Medtronic, INC. | $771.36 | 2021-2024 | Ffrangio |
| Merz North America, INC. | $250.96 | 2019-2023 | |
| Medtronic Vascular, INC. | $157.56 | 2019 | |
| Impulse Dynamics (USA) INC. | $115.93 | 2022 | |
| Abbott Laboratories | $43.49 | 2024 | Aveir |
| Cvrx, INC. | $32.13 | 2021 | |
| Revance Therapeutics, INC. | $13.64 | 2025 | Daxxify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Altman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.